Page 3 - James George Chopas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James george chopas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James George Chopas Today - Breaking & Trending Today

Apellis Pharmaceuticals (NASDAQ:APLS) Shares Gap Down Following Insider Selling

Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) gapped down before the market opened on Tuesday following insider selling activity. The stock had previously closed at $65.45, but opened at $63.81. Apellis Pharmaceuticals shares last traded at $63.90, with a volume of 195,943 shares changing hands. Specifically, CAO James George Chopas sold 864 […] ....

James George Chopas , Raymond James , Davido Watson , Institutional Trading Of Apellis Pharmaceuticals , National Bank , Stephens Consulting , Apellis Pharmaceuticals , News Ratings For Apellis Pharmaceuticals Daily , Jpmorgan Chase Co , Apellis Pharmaceuticals Inc , Covestor Ltd , Apellis Pharmaceuticals Stock , First Horizon Advisors Inc , Wealth Management Inc , Get Free Report , George Chopas , General Counsel David , Horizon Advisors , Apellis Pharmaceuticals Daily , Nasdaq Apls ,

Apellis Pharmaceuticals (NASDAQ:APLS) Shares Gap Down After Insider Selling

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report)’s share price gapped down prior to trading on Tuesday after an insider sold shares in the company. The stock had previously closed at $65.45, but opened at $63.81. Apellis Pharmaceuticals shares last traded at $63.90, with a volume of 195,943 shares changing hands. Specifically, insider Jeffrey Eisele […] ....

James George Chopas , Jeffrey Eisele , Robertw Baird , Apellis Pharmaceuticals Inc , Apellis Pharmaceuticals , Norges Bank , Institutional Investors Weigh In On Apellis Pharmaceuticals , Apellis Pharmaceuticals Company Profile , News Ratings For Apellis Pharmaceuticals Daily , Apellis Pharmaceuticals Stock Performance , Jennison Associates , Needham Company , Securities Exchange Commission , Goldman Sachs Group , Pricet Rowe Associates Inc , Morgan Stanley , Get Free Report , Exchange Commission , George Chopas , Apellis Pharmaceuticals Daily , Nasdaq Apls ,

Assetmark Inc. Raises Holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

Assetmark Inc. grew its position in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 88.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,369 shares of the company’s stock after purchasing an additional 5,339 shares during […] ....

United States , James George Chopas , Jeffrey Eisele , Robertw Baird , Apellis Pharmaceuticals Inc , Perceptive Advisors , Pricet Rowe Associates Inc , Assetmark Inc , Apellis Pharmaceuticals , Vanguard Group Inc , Needham Company , Norges Bank , Jpmorgan Chase Co , Wells Fargo Company , Quarter For Apellis Pharmaceuticals , Apellis Pharmaceuticals Stock Performance , Securities Exchange Commission , News Ratings For Apellis Pharmaceuticals Daily , Free Report , Street Corp , Get Free Report , George Chopas , Exchange Commission , Visit Holdingschannel , Apellis Pharmaceuticals Daily , Nasdaq Apls ,